Guidance may not be applicable to all patients, interventions, diseases or stages of diseases. Guidance is based on review and analysis of relevant literature and is not intended as a statement of the ...

Recurrent squamous cell carcinoma in situ of the distal interphalangeal joint of the left third finger, involving the proximal nail fold and extending posteriorly. Final defect after two stages of ...

The following is a summary of “Oncologic outcomes for invasive squamous cell carcinoma with a clinically resolved biopsy site ...

This includes skin cancers like the following: Basal cell carcinoma (BCC) is the most common type of skin cancer. It starts in the top layer of the skin in cells called basal cells. Squamous cell ...

The US Food and Drug Administration (FDA) has approved Unloxcyt (cosibelimab-ipdl) for the treatment of adults with metastatic cutaneous squamous cell carcinoma (CSCC) or locally advanced CSCC who are ...

the condition was thought to be of limited malignant potential with a histologically intermediate stage between benign hyper plasia and squamous cell carcinoma (Bart & Kopf, 1977; Read & Abell ...

Non-small-cell ... cancer cells that have spread to other parts of the body. Additionally, many chemotherapy agents make the cancer more sensitive to the radiotherapy. NICE recommends that ...